Delivery Order SPE2DR25D2007-SPE2DR26FM09A
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $5,258.71. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Pantoprazole Sodium Delayed-Release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $2,058.66. This competitive award, which utilizes firm fixed price pricing, represents a non-set-aside contract and is scheduled for completion by August 29, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a contract value of $1,013.16. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively awarded. The order is set for ultimate completion on August 1, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $1,129.71. This contract represents a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and was awarded without set-aside provisions through open competition. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,119.58 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in quantities of 1,000 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for ultimate completion on September 17, 2025, with performance occurring at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a contract ceiling value of $3,894.81. This competitively awarded, firm fixed-price delivery order is not set-aside and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. The order represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a contract ceiling value of $1,083.78. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of Pantoprazole Sodium Delayed-Release 40 mg tablets (1,000 count) at a firm fixed price of $1,094.58. This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Pantoprazole Sodium Delayed-Release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $2,535.19. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on September 23, 2025, and will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $3,604.57 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of 1,000 tablets of Pantoprazole Sodium delayed-release 40 mg. This competitive delivery order, which is set to be completed by September 18, 2025, represents a firm fixed-price transaction issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through December 2026). The...
- SPE2DR25D2007Indefinite Delivery Contract
- SPE2DR25D2007-SPE2DR26FM09ADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $7,351.73. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded competitively. The contract is scheduled for ultimate completion on November 6, 2025, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive IDC vehicle enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare systems globally. AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, and this award exemplifies the company's role in fulfilling routine pharmaceutical supply needs across the Defense Health Agency and related military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 11/5/25 |